Goldman Sachs upgraded Merck (NYSE: MRK) from Neutral to Conviction Buy with a price target of $73.00 (from $63.00).Analyst Jami ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE